1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Asia-Pacific Tissue Engineered - Skin Substitute Procedures Outlook to 2020

Asia-Pacific Tissue Engineered - Skin Substitute Procedures Outlook to 2020

Summary

GlobalData’s new report, "Asia-Pacific Tissue Engineered - Skin Substitute Procedures Outlook to 2020", provides key procedures data on the Asia-Pacific Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Tissue Engineered - Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes data for Tissue Engineered - Skin Substitute Procedures segments - Tissue Engineered - Skin Substitute Procedures Tissue Engineered - Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures).
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

Asia-Pacific Tissue Engineered - Skin Substitute Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Tissue Engineered - Skin Substitute Procedures Segmentation 6
2.3 Definitions of Procedures Covered in the Report 6
3 Tissue Engineered - Skin Substitute Procedures, Asia-Pacific 7
3.1 Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, 2005-2020 7
3.2 Tissue Engineered - Skin Substitute Procedures, Asia Pacific Category Comparison by Procedures, 2005-2020 9
3.3 Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, 2005-2013 10
3.4 Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, 2013-2020 12
4 Tissue Engineered - Skin Substitute Procedures, Australia 14
4.1 Tissue Engineered - Skin Substitute Procedures, Australia, 2005-2013 14
4.2 Tissue Engineered - Skin Substitute Procedures, Australia, 2013-2020 16
4.2.1 Biologic Skin Substitute Procedures, Australia, 2005-2013 18
4.2.1.1 Allograft Procedures, Australia, 2005-2013 20
4.2.2 Biologic Skin Substitute Procedures, Australia, 2013-2020 22
4.2.2.1 Allograft Procedures, Australia, 2013-2020 24
5 Tissue Engineered - Skin Substitute Procedures, China 26
5.1 Tissue Engineered - Skin Substitute Procedures, China, 2005-2013 26
5.2 Tissue Engineered - Skin Substitute Procedures, China, 2013-2020 28
5.2.1 Biologic Skin Substitute (Allograft) Procedures, China, 2005-2013 30
5.2.2 Biologic Skin Substitute (Allograft) Procedures, China, 2013-2020 32
6 Tissue Engineered - Skin Substitute Procedures, India 34
6.1 Tissue Engineered - Skin Substitute Procedures, India, 2005-2013 34
6.2 Tissue Engineered - Skin Substitute Procedures, India, 2013-2020 36
6.2.1 Biologic Skin Substitute Procedures, India, 2005-2013 38
6.2.1.1 Allograft Procedures, India, 2005-2013 40
6.2.2 Biologic Skin Substitute Procedures, India, 2013-2020 42
6.2.2.1 Allograft Procedures, India, 2013-2020 44
7 Tissue Engineered - Skin Substitute Procedures, Japan 46
7.1 Tissue Engineered - Skin Substitute Procedures, Japan, 2005-2013 46
7.2 Tissue Engineered - Skin Substitute Procedures, Japan, 2013-2020 48
7.2.1 Biologic Skin Substitute Procedures, Japan, 2005-2013 50
7.2.1.1 Allograft Procedures, Japan, 2005-2013 52
7.2.2 Biologic Skin Substitute Procedures, Japan, 2013-2020 54
7.2.2.1 Allograft Procedures, Japan, 2013-2020 56
8 Tissue Engineered - Skin Substitute Procedures, South Korea 58
8.1 Tissue Engineered - Skin Substitute Procedures, South Korea, 2005-2013 58
8.2 Tissue Engineered - Skin Substitute Procedures, South Korea, 2013-2020 60
8.2.1 Biologic Skin Substitute Procedures, South Korea, 2005-2013 62
8.2.1.1 Allograft Procedures, South Korea, 2005-2013 64
8.2.2 Biologic Skin Substitute Procedures, South Korea, 2013-2020 66
8.2.2.1 Allograft Procedures, South Korea, 2013-2020 68
9 Appendix 70
9.1 Research Methodology 71
9.1.1 Coverage 71
9.1.2 Secondary Research 71
9.1.3 Primary Research 72
9.1.4 Market Modeling and Forecasting 73
9.1.5 Company Share Analysis 76
9.1.6 Distribution Share Analysis 77
9.2 Expert Panel 77
9.3 GlobalData Consulting 78
9.4 Contact Us 78
9.5 Disclaimer 78

1.1 List of Tables
Table 1: Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, 2005-2020 8
Table 2: Tissue Engineered - Skin Substitute Procedures Asia Pacific Category Comparison by Procedures, 2005-2020 9
Table 3: Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, Historic, 2005-2013 11
Table 4: Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, Forecast, 2013-2020 13
Table 5: Tissue Engineered - Skin Substitute Procedures, Australia, Historic, 2005-2013 15
Table 6: Tissue Engineered - Skin Substitute Procedures, Australia, Forecast, 2013-2020 17
Table 7: Biologic Skin Substitute Procedures, Australia, Historic, 2005-2013 19
Table 8: Allograft Procedures, Australia, Historic, 2005-2013 21
Table 9: Biologic Skin Substitute Procedures, Australia, Forecast, 2013-2020 23
Table 10: Allograft Procedures, Australia, Forecast, 2013-2020 25
Table 11: Tissue Engineered - Skin Substitute Procedures, China, Historic, 2005-2013 27
Table 12: Tissue Engineered - Skin Substitute Procedures, China, Forecast, 2013-2020 29
Table 13: Biologic Skin Substitute (Allograft) Procedures, China, Historic, 2005-2013 31
Table 14: Biologic Skin Substitute (Allograft) Procedures, China, Forecast, 2013-2020 33
Table 15: Tissue Engineered - Skin Substitute Procedures, India, Historic, 2005-2013 35
Table 16: Tissue Engineered - Skin Substitute Procedures, India, Forecast, 2013-2020 37
Table 17: Biologic Skin Substitute Procedures, India, Historic, 2005-2013 39
Table 18: Allograft Procedures, India, Historic, 2005-2013 41
Table 19: Biologic Skin Substitute Procedures, India, Forecast, 2013-2020 43
Table 20: Allograft Procedures, India, Forecast, 2013-2020 45
Table 21: Tissue Engineered - Skin Substitute Procedures, Japan, Historic, 2005-2013 47
Table 22: Tissue Engineered - Skin Substitute Procedures, Japan, Forecast, 2013-2020 49
Table 23: Biologic Skin Substitute Procedures, Japan, Historic, 2005-2013 51
Table 24: Allograft Procedures, Japan, Historic, 2005-2013 53
Table 25: Biologic Skin Substitute Procedures, Japan, Forecast, 2013-2020 55
Table 26: Allograft Procedures, Japan, Forecast, 2013-2020 57
Table 27: Tissue Engineered - Skin Substitute Procedures, South Korea, Historic, 2005-2013 59
Table 28: Tissue Engineered - Skin Substitute Procedures, South Korea, Forecast, 2013-2020 61
Table 29: Biologic Skin Substitute Procedures, South Korea, Historic, 2005-2013 63
Table 30: Allograft Procedures, South Korea, Historic, 2005-2013 65
Table 31: Biologic Skin Substitute Procedures, South Korea, Forecast, 2013-2020 67
Table 32: Allograft Procedures, South Korea, Forecast, 2013-2020 69
Table 33: Total Number of Primary Research Participants, Wound Care Management, by Country 73

1.2 List of Figures
Figure 1: Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, 2005-2020 7
Figure 2: Tissue Engineered - Skin Substitute Procedures, Asia Pacific Category Comparison by Procedures, 2005-2020 9
Figure 3: Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, Historic, 2005-2013 10
Figure 4: Tissue Engineered - Skin Substitute Procedures, Asia-Pacific, Forecast, 2013-2020 12
Figure 5: Tissue Engineered - Skin Substitute Procedures, Australia, Historic, 2005-2013 14
Figure 6: Tissue Engineered - Skin Substitute Procedures, Australia, Forecast, 2013-2020 16
Figure 7: Biologic Skin Substitute Procedures, Australia, Historic, 2005-2013 18
Figure 8: Allograft Procedures, Australia, Historic, 2005-2013 20
Figure 9: Biologic Skin Substitute Procedures, Australia, Forecast, 2013-2020 22
Figure 10: Allograft Procedures, Australia, Forecast, 2013-2020 24
Figure 11: Tissue Engineered - Skin Substitute Procedures, China, Historic, 2005-2013 26
Figure 12: Tissue Engineered - Skin Substitute Procedures, China, Forecast, 2013-2020 28
Figure 13: Biologic Skin Substitute (Allograft) Procedures, China, Historic, 2005-2013 30
Figure 14: Biologic Skin Substitute (Allograft) Procedures, China, Forecast, 2013-2020 32
Figure 15: Tissue Engineered - Skin Substitute Procedures, India, Historic, 2005-2013 34
Figure 16: Tissue Engineered - Skin Substitute Procedures, India, Forecast, 2013-2020 36
Figure 17: Biologic Skin Substitute Procedures, India, Historic, 2005-2013 38
Figure 18: Allograft Procedures, India, Historic, 2005-2013 40
Figure 19: Biologic Skin Substitute Procedures, India, Forecast, 2013-2020 42
Figure 20: Allograft Procedures, India, Forecast, 2013-2020 44
Figure 21: Tissue Engineered - Skin Substitute Procedures, Japan, Historic, 2005-2013 46
Figure 22: Tissue Engineered - Skin Substitute Procedures, Japan, Forecast, 2013-2020 48
Figure 23: Biologic Skin Substitute Procedures, Japan, Historic, 2005-2013 50
Figure 24: Allograft Procedures, Japan, Historic, 2005-2013 52
Figure 25: Biologic Skin Substitute Procedures, Japan, Forecast, 2013-2020 54
Figure 26: Allograft Procedures, Japan, Forecast, 2013-2020 56
Figure 27: Tissue Engineered - Skin Substitute Procedures, South Korea, Historic, 2005-2013 58
Figure 28: Tissue Engineered - Skin Substitute Procedures, South Korea, Forecast, 2013-2020 60
Figure 29: Biologic Skin Substitute Procedures, South Korea, Historic, 2005-2013 62
Figure 30: Allograft Procedures, South Korea, Historic, 2005-2013 64
Figure 31: Biologic Skin Substitute Procedures, South Korea, Forecast, 2013-2020 66
Figure 32: Allograft Procedures, South Korea, Forecast, 2013-2020 68
Figure 33: GlobalData Epidemiology-Based Forecasting Model 75
Figure 34: GlobalData Capital Equipment-Based Forecasting Model 76
Figure 35: Primary Interviews by Participant Type (%) 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Active Wound Care Market Research Report 2016

Global Active Wound Care Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Active Wound Care Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Active Wound Care industry, focusing on the main regions ...

Global Tissue Engineered Skin Substitute Report-Market Size and Forecast 2016

Global Tissue Engineered Skin Substitute Report-Market Size and Forecast 2016

  • $ 2850
  • Industry report
  • July 2016
  • by 9Dimen Research

2016 Global Tissue Engineered Skin Substitute Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Tissue Engineered Skin Substitute industry, ...

Canada Wound Care Management Devices Market - Growth, Trends, and Forecasts (2016-2021)

Canada Wound Care Management Devices Market - Growth, Trends, and Forecasts (2016-2021)

  • $ 32550
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Canadian Wound Care Management Devices (WCMD) market was estimated at USD XX billion in 2016 and is projected to reach USD XX by 2021, at a CAGR of about XX% during the forecast period from 2016 to ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.